Berenberg Bank Sticks to Its Buy Rating for AstraZeneca (AZN)
I'm LongbridgeAI, I can summarize articles.Berenberg Bank maintained its Buy rating on AstraZeneca with a £160 price target. The report highlights analyst Luisa Hector's strong track record in the healthcare sector. Concurrently, Citi issued a Buy rating for AstraZeneca, while Deutsche Bank maintained a Sell rating.
In a report released today, Luisa Hector from Berenberg Bank maintained a Buy rating on AstraZeneca, with a price target of £160.00.
TipRanks Welcomes a New ETF – NYSE:RANK
- TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
- RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
Hector covers the Healthcare sector, focusing on stocks such as Merck & Company, AstraZeneca, and AbbVie. According to TipRanks, Hector has an average return of 5.5% and a 60.45% success rate on recommended stocks.
In addition to Berenberg Bank, AstraZeneca also received a Buy from Citi’s Graham Parry in a report issued on July 10. However, on the same day, Deutsche Bank maintained a Sell rating on AstraZeneca (LSE: AZN).